Yu-Wei Wang (Yuwei Wang)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 19

Top Topics

Molecular Dynamics Simulations

Allogeneic Hematopoietic Stem Cell Transplantation

Structure Activity Relationship

Drug Administration

Top Venues

International journal of molecular sciences

Journal of medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

Chemical biology & drug design

This page only lists publications with an associated author ORCID identifier.

Publications

Haiting Duan, Jingyu Zhang, Renzhao Gui, Yang Lu, Ao Pang, Beijing Chen, Liteng Shen, Hengyuan Yu, Jia Li, Tengfei Xu, Yu-Wei Wang, Xiao-Jun Yao, Bo Zhang, Nengming Lin, Xiao-Wu Dong, Yubo Zhou, Yong-Zhou Hu
Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors. Journal of medicinal chemistry 67 (13) (2024)
Yifan Wang, Shunjiang Jia, Fan Wang, Ruizhe Jiang, Xiaodan Yin, Shuo Wang, Ruyi Jin, Hui Guo, Yuping Tang, Yu-Wei Wang
3D-QSAR, Scaffold Hopping, Virtual Screening, and Molecular Dynamics Simulations of Pyridin-2-one as mIDH1 Inhibitors. International journal of molecular sciences 25 (13) (2024)
Haiting Duan, Jingyu Zhang, Renzhao Gui, Yang Lu, Ao Pang, Beijing Chen, Liteng Shen, Hengyuan Yu, Jia Li, Tengfei Xu, Yu-Wei Wang, Xiao-Jun Yao, Bo Zhang, Nengming Lin, Xiao-Wu Dong, Yubo Zhou, Yong-Zhou Hu
Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors. Journal of medicinal chemistry 67 (13) (2024)
Mingfei Wu, Yiquan Wu, Yuyuan Jin, Xinfei Mao, Shenxin Zeng, Hengyuan Yu, Jingyu Zhang, Yuheng Jin, Yizhe Wu, Tengfei Xu, Yong Chen, Yu-Wei Wang, Xiaojun Yao, Yong-Zhou Hu, Wenhai Huang, Xiao-Wu Dong
Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy. Journal of medicinal chemistry (2024)
Mingfei Wu, Yiquan Wu, Yuyuan Jin, Xinfei Mao, Shenxin Zeng, Hengyuan Yu, Jingyu Zhang, Yuheng Jin, Yizhe Wu, Tengfei Xu, Yong Chen, Yu-Wei Wang, Xiaojun Yao, Yong-Zhou Hu, Wenhai Huang, Xiao-Wu Dong
Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy. Journal of medicinal chemistry 67 (16) (2024)
Weitong Zhang, Hailong Bai, Yifan Wang, Xiaorui Wang, Ruyi Jin, Hui Guo, Huanling Lai, Yuping Tang, Yu-Wei Wang
Identification of mIDH1 R132C/S280F Inhibitors from Natural Products by Integrated Molecular Docking, Pharmacophore Modeling and Molecular Dynamics Simulations. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Hui-Xian Liu, Wen-Yu Yao, Ge Cui, Jing Zhou, Hao Yan, Hui Guo, Yu-Wei Wang, Yue Zhang
Design, synthesis, and antibacterial activity of pleuromutilin derivatives. Chemical biology & drug design 103 (6) (2024)
Mingfei Wu, Yiquan Wu, Yuyuan Jin, Xinfei Mao, Shenxin Zeng, Hengyuan Yu, Jingyu Zhang, Yuheng Jin, Yizhe Wu, Tengfei Xu, Yong Chen, Yu-Wei Wang, Xiaojun Yao, Yong-Zhou Hu, Wenhai Huang, Xiao-Wu Dong
Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy. Journal of medicinal chemistry 67 (16) (2024)
Haiting Duan, Jingyu Zhang, Renzhao Gui, Yang Lu, Ao Pang, Beijing Chen, Liteng Shen, Hengyuan Yu, Jia Li, Tengfei Xu, Yu-Wei Wang, Xiao-Jun Yao, Bo Zhang, Nengming Lin, Xiao-Wu Dong, Yubo Zhou, Yong-Zhou Hu
Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors. Journal of medicinal chemistry (2024)
Weitong Zhang, Hailong Bai, Yifan Wang, Xiaorui Wang, Ruyi Jin, Hui Guo, Huanling Lai, Yuping Tang, Yu-Wei Wang
Identification of mIDH1 R132C/S280F Inhibitors from Natural Products by Integrated Molecular Docking, Pharmacophore Modeling and Molecular Dynamics Simulations. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Yifan Wang, Shunjiang Jia, Fan Wang, Ruizhe Jiang, Xiaodan Yin, Shuo Wang, Ruyi Jin, Hui Guo, Yuping Tang, Yu-Wei Wang
3D-QSAR, Scaffold Hopping, Virtual Screening, and Molecular Dynamics Simulations of Pyridin-2-one as mIDH1 Inhibitors. International journal of molecular sciences 25 (13) (2024)
Weitong Zhang, Hailong Bai, Yifan Wang, Xiaorui Wang, Ruyi Jin, Hui Guo, Huanling Lai, Yuping Tang, Yu-Wei Wang
Identification of mIDH1 R132C/S280F Inhibitors from Natural Products by Integrated Molecular Docking, Pharmacophore Modeling and Molecular Dynamics Simulations. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Fengling Wang, Wenling Ye, Yongxing He, Haiyang Zhong, Yongchang Zhu, Jianting Han, Xiaoqing Gong, Yanan Tian, Yu-Wei Wang, Shuang Wang, Shaoping Ji, Huan-Xiang Liu, Xiaojun Yao
Identification of CBPA as a New Inhibitor of PD-1/PD-L1 Interaction. International journal of molecular sciences 24 (4) (2023)
Fengling Wang, Wenling Ye, Yongxing He, Haiyang Zhong, Yongchang Zhu, Jianting Han, Xiaoqing Gong, Yanan Tian, Yu-Wei Wang, Shuang Wang, Shaoping Ji, Huan-Xiang Liu, Xiaojun Yao
Identification of CBPA as a New Inhibitor of PD-1/PD-L1 Interaction. International journal of molecular sciences 24 (4) (2023)
Jumin Huang, Fugang Duan, Chun Xie, Jiahui Xu, Yizhong Zhang, Yu-Wei Wang, Yu-Ping Tang, Elaine Lai-Han Leung
Microbes mediated immunogenic cell death in cancer immunotherapy. Immunological reviews (2023)
Fengling Wang, Wenling Ye, Yongxing He, Haiyang Zhong, Yongchang Zhu, Jianting Han, Xiaoqing Gong, Yanan Tian, Yu-Wei Wang, Shuang Wang, Shaoping Ji, Huan-Xiang Liu, Xiaojun Yao
Identification of CBPA as a New Inhibitor of PD-1/PD-L1 Interaction. International journal of molecular sciences 24 (4) (2023)
Fengling Wang, Wenling Ye, Yongxing He, Haiyang Zhong, Yongchang Zhu, Jianting Han, Xiaoqing Gong, Yanan Tian, Yu-Wei Wang, Shuang Wang, Shaoping Ji, Huan-Xiang Liu, Xiaojun Yao
Identification of CBPA as a New Inhibitor of PD-1/PD-L1 Interaction. International journal of molecular sciences 24 (4) (2023)
Fengling Wang, Wenling Ye, Yongxing He, Haiyang Zhong, Yongchang Zhu, Jianting Han, Xiaoqing Gong, Yanan Tian, Yu-Wei Wang, Shuang Wang, Shaoping Ji, Huan-Xiang Liu, Xiaojun Yao
Identification of CBPA as a New Inhibitor of PD-1/PD-L1 Interaction. International journal of molecular sciences 24 (4) (2023)
Jingli Liu, Hui Guo, Jing Zhou, Yu-Wei Wang, Hao Yan, Ruyi Jin, Yuping Tang
Evodiamine and Rutaecarpine as Potential Anticancer Compounds: A Combined Computational Study. International journal of molecular sciences 23 (19) (2022)